Trial intelligence / Profile preview

Effect of intraperitoneal bupivacaine on postoperative pain

IRCT20140109016151N6Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of bupivacaine in class III obesity, sponsored by Iran University of Medical Sciences. Started Sep 2017; status: completed.

02

Drugs

bupivacaine
03

Conditions

class III obesity

Beyond the preview

Go deeper on IRCT20140109016151N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20140109016151N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call